Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?

Marchlinski, Francis E; Oraii, Alireza; Muser, Daniele

Marchlinski, Francis E; Oraii, Alireza; Muser, Daniele.

Afiliación

Marchlinski FE; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.
Oraii A; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.
Muser D; Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Pavilion, 2 City, 1 Convention Ave, Philadelphia, PA 19104, USA.

Eur Heart J ; 45(1): 67-69, 2024 Jan 01.

Article en En | MEDLINE | ID: mdl-37995207

Asunto(s)

Fibrilación Atrial; Accidente Cerebrovascular; Humanos; Fibrilación Atrial/complicaciones; Fibrilación Atrial/tratamiento farmacológico; Accidente Cerebrovascular/etiología; Accidente Cerebrovascular/prevención & control; Anticoagulantes/uso terapéutico; Factores de Riesgo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Accidente Cerebrovascular Límite: Humans Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google